We also demonstrated that a reduction of PGM1 levels in CRC cells stimulates both cellular proliferation and tumor growth by causing the cells to shift from glycogen synthesis and divert glucose to glycolytic pathways. The gene discussed is PGM1; the disease is colorectal carcinoma.